Checkpoint molecule PD-1-assisted CD8+ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

Overview of attention for article published in Cancer Management and Research, September 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,952 followers.

RT @keisuke4713: ▶️CD8+T細胞枯渇→癌⬆️？治療後PD-1+CD8+T細胞数⬇️は⽣存⬆️？ PD-1支援のCD8+Tリンパ球数 tyrosine kinase阻害剤治療した転移性腎細胞癌患者で生存予測 https://t.co/LGsul35YvE…

19 Apr 2024

Reply Repost Favourite

▶️CD8+T細胞枯渇→癌⬆️？治療後PD-1+CD8+T細胞数⬇️は⽣存⬆️？ PD-1支援のCD8+Tリンパ球数 tyrosine kinase阻害剤治療した転移性腎細胞癌患者で生存予測 https://t.co/LGsul35YvE 非小細胞肺癌 PD-1遮断治療反応予測:循環PD-1+CD8+Tリンパ球 https://t.co/4dAC24RSMa

17 Apr 2024

Reply Repost Favourite

Dove Medical Press

Article Metrics

Checkpoint molecule PD-1-assisted CD8+ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

Mentioned by

Citations

Readers on